Stay updated on Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    The footer revision number changes from v3.7.0 to v3.7.1. The page continues to display a 403 Forbidden error rather than the study record.
    Difference
    0.2%
    Check dated 2026-10-11T14:40:03.000Z thumbnail image
  2. Check
    10 days ago
    No Change Detected
  3. Check
    17 days ago
    No Change Detected
  4. Check
    24 days ago
    Change Detected
    Summary
    The page now displays a 403 Forbidden error, indicating access to the study record is blocked. The header and footer remain visible, but no study details are accessible.
    Difference
    19%
    Check dated 2026-09-20T15:28:38.000Z thumbnail image
  5. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.6.5 to v3.6.6 on the study record, indicating a minor maintenance update to the page. This does not affect study content or user actions.
    Difference
    0.1%
    Check dated 2026-08-29T23:55:16.000Z thumbnail image
  6. Check
    67 days ago
    Change Detected
    Summary
    Page revision updated from v3.6.4 to v3.6.5, indicating a new published version without changes to study information.
    Difference
    0.1%
    Check dated 2026-08-08T23:38:01.000Z thumbnail image
  7. Check
    81 days ago
    Change Detected
    Summary
    The page revision was updated from v3.6.3 to v3.6.4, signaling a minor editorial/technical update to the ClinicalTrials.gov entry.
    Difference
    0.1%
    Check dated 2026-07-25T16:52:49.000Z thumbnail image
  8. Check
    102 days ago
    Change Detected
    Summary
    The footer now displays Revision: v3.6.3, replacing the previous v3.6.2. This reflects a minor platform update and does not modify the study content or user-facing information.
    Difference
    0.1%
    Check dated 2026-07-04T13:12:22.000Z thumbnail image

Stay in the know with updates to Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Post-HLA Mismatched BMT in Sarcoma Clinical Trial page.